A molecule has been shown to increase dopamine levels in the brains of mice, offering hope for stopping the progression of Parkinson’s.
List view / Grid view
Filter the results
Currently, there is no licensed treatment to slow or stop the progression of Parkinson’s disease. However, a team at Sheffield University in the UK are currently working to identify compounds that target the dopaminergic brain cells affected by the disease. Nikki Withers speaks to Dr Heather Mortiboys to hear how…
A new study has identified a molecule which targets a protein linked with Parkinson’s.
Drug Target Review welcomes Janusz Kulagowski to its advisory board ...